Related Experiment Videos
Lipid binding inhibits alpha-synuclein fibril formation
1Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064, USA.
The Journal of Biological Chemistry
|March 7, 2003
Summary
Alpha-synuclein aggregation is key in Parkinson's disease. Its interaction with lipid vesicles, forming helical structures, inhibits fibrillation, suggesting membrane-bound alpha-synuclein may not cause disease.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Parkinson's disease (PD) is the second most common neurodegenerative disorder.
- Alpha-synuclein aggregation is implicated in PD etiology, but its function and interactions are unclear.
- The protein alpha-synuclein is intrinsically unfolded and contains lipid-binding motifs.
Purpose of the Study:
- To investigate the interaction of alpha-synuclein with lipid vesicles.
- To determine how vesicle properties influence alpha-synuclein conformation and fibrillation.
- To explore the physiological significance of alpha-synuclein's membrane interactions.
Main Methods:
- Studied alpha-synuclein interaction with various lipid vesicles.
- Monitored changes in protein conformation (secondary structure) using spectroscopy.
- Assessed the kinetics of alpha-synuclein fibrillation under different conditions.
Main Results:
- Alpha-synuclein interaction with vesicles strongly depended on phospholipid composition, protein-to-lipid ratio, and vesicle size.
- Specific phospholipid compositions induced helical structures in alpha-synuclein.
- A strong correlation existed between alpha-helix induction and inhibition of fibril formation.
Conclusions:
- Helical, membrane-bound alpha-synuclein is unlikely to aggregate and form fibrils.
- This finding is physiologically significant, as alpha-synuclein is membrane-bound in dopaminergic neurons.
- Understanding these interactions may offer insights into Parkinson's disease pathogenesis.